annb0t
Top 20
ResMed (RMD) reported $1.2 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 7.2%. EPS of $2.13 for the same period compares to $1.68 a year ago.
The reported revenue represents a surprise of +1.90% over the Zacks Consensus Estimate of $1.17 billion. With the consensus EPS estimate being $1.92, the EPS surprise was +10.94%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to de...
>>> Read more: Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
The reported revenue represents a surprise of +1.90% over the Zacks Consensus Estimate of $1.17 billion. With the consensus EPS estimate being $1.92, the EPS surprise was +10.94%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to de...
>>> Read more: Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
